Genetic and Clinical Characteristics of Korean Patients with Isolated Hypoparathyroidism: from the Korean Hypopara Registry Study

Overview

Journal J Korean Med Sci

Specialty General Medicine

Date 2013 Oct 18

PMID 24133354

Citations 5

Authors

So Young Park

Young Sil Eom

Byoungho Choi

Hyon-Seung Yi

Seung-Hee Yu

Kiyoung Lee

Hyun-Seok Jin

Yoon-Sok Chung

Tae Sik Jung

Sihoon Lee

Affiliations

Soon will be listed here.

Abstract

Isolated hypoparathyroidism (IH) shows heterogeneous phenotypes and can be caused by defects in a variety of genes. The goal of our study was to determine the clinical features and to analyze gene mutations in a large cohort of Korean patients with sporadic or familial IH. We recruited 23 patients. They showed a broad range of onset age and various values of biochemical data. Whole exome sequencing was performed on two affected cases and one unaffected individual in a family. All coding exons and exon-intron borders of GCMB, CASR, and prepro-PTH were sequenced using PCR-amplified DNA. In one family who underwent the whole exome sequencing analysis, approximately 300 single nucleotide changes emerged as candidates for genetic alteration. Among them, we identified a functional mutation in exon 2 of GCMB (C106R) in two affected cases. Besides, heterozygous gain-of-function mutations in the CASR gene were found in other subjects; D410E and P221L. We also found one single nucleotide polymorphism (SNP) in the prepro-PTH gene, five SNPs in the CASR gene, and four SNPs in the GCMB gene. The current study represents a variety of biochemical phenotypes in IH patients with the molecular genetic diagnosis of IH.

Citing Articles

Hypoparathyroidism: Similarities and differences between Western and Eastern countries.

Yang Y, Deng Y, Sun L, Rejnmark L, Wang L, Pietschmann P Osteoporos Int. 2025; 36(3):391-402.

PMID: 39777494 DOI: 10.1007/s00198-024-07352-6.

Novel PTH Gene Mutations Causing Isolated Hypoparathyroidism.

Hawkes C, Al Jubeh J, Li D, Tucker S, Rajiyah T, Levine M J Clin Endocrinol Metab. 2022; 107(6):e2449-e2458.

PMID: 35165722 PMC: 9113798. DOI: 10.1210/clinem/dgac086.

Search for Novel Mutational Targets in Human Endocrine Diseases.

Park S, Seo M, Lee S Endocrinol Metab (Seoul). 2019; 34(1):23-28.

PMID: 30912335 PMC: 6435846. DOI: 10.3803/EnM.2019.34.1.23.

Short stature and hypoparathyroidism in a child with Kenny-Caffey syndrome type 2 due to a novel mutation in gene.

Abraham M, Li D, Tang D, OConnell S, McKenzie F, Lim E Int J Pediatr Endocrinol. 2017; 2017:1.

PMID: 28138333 PMC: 5264330. DOI: 10.1186/s13633-016-0041-7.

Polymorphisms of CASR gene increase the risk of primary hyperparathyroidism.

Wang X, Wu Y, Li Z, Zhao X, Lv S, Wang X J Endocrinol Invest. 2015; 39(6):617-25.

PMID: 26710757 DOI: 10.1007/s40618-015-0405-5.

References

Mitchell D, Regan S, Cooley M, Lauter K, Vrla M, Becker C . Long-term follow-up of patients with hypoparathyroidism. J Clin Endocrinol Metab. 2012; 97(12):4507-14. PMC: 3513540. DOI: 10.1210/jc.2012-1808. View

Husebye E . Functional autoantibodies cause hypoparathyroidism. J Clin Endocrinol Metab. 2009; 94(12):4655-7. DOI: 10.1210/jc.2009-2123. View

Li Y, Song Y, Rais N, Connor E, Schatz D, Muir A . Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism. J Clin Invest. 1996; 97(4):910-4. PMC: 507135. DOI: 10.1172/JCI118513. View

Goswami R, Brown E, Kochupillai N, Gupta N, Rani R, Kifor O . Prevalence of calcium sensing receptor autoantibodies in patients with sporadic idiopathic hypoparathyroidism. Eur J Endocrinol. 2004; 150(1):9-18. DOI: 10.1530/eje.0.1500009. View

Scillitani A, Guarnieri V, De Geronimo S, Muscarella L, Battista C, DAgruma L . Blood ionized calcium is associated with clustered polymorphisms in the carboxyl-terminal tail of the calcium-sensing receptor. J Clin Endocrinol Metab. 2004; 89(11):5634-8. DOI: 10.1210/jc.2004-0129. View

Bamshad M, Ng S, Bigham A, Tabor H, Emond M, Nickerson D . Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet. 2011; 12(11):745-55. DOI: 10.1038/nrg3031. View

Breslau N . Normal and abnormal regulation of 1,25-(OH)2D synthesis. Am J Med Sci. 1988; 296(6):417-25. DOI: 10.1097/00000441-198812000-00009. View

Kim M, Tan A, Ki C, Lee J, Jang H, Shin H . Autosomal dominant hypocalcemia caused by an activating mutation of the calcium-sensing receptor gene: the first case report in Korea. J Korean Med Sci. 2010; 25(2):317-20. PMC: 2811305. DOI: 10.3346/jkms.2010.25.2.317. View

Choi H, Oh H, Choi H, Choi W, Kim J, Kim K . Vitamin D insufficiency in Korea--a greater threat to younger generation: the Korea National Health and Nutrition Examination Survey (KNHANES) 2008. J Clin Endocrinol Metab. 2010; 96(3):643-51. DOI: 10.1210/jc.2010-2133. View

10.

Egbuna O, Brown E . Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations. Best Pract Res Clin Rheumatol. 2008; 22(1):129-48. PMC: 2364635. DOI: 10.1016/j.berh.2007.11.006. View

11.

Raue F, Pichl J, Dorr H, Schnabel D, Heidemann P, Hammersen G . Activating mutations in the calcium-sensing receptor: genetic and clinical spectrum in 25 patients with autosomal dominant hypocalcaemia - a German survey. Clin Endocrinol (Oxf). 2011; 75(6):760-5. DOI: 10.1111/j.1365-2265.2011.04142.x. View

12.

Arnold A, Horst S, Gardella T, Baba H, Levine M, Kronenberg H . Mutation of the signal peptide-encoding region of the preproparathyroid hormone gene in familial isolated hypoparathyroidism. J Clin Invest. 1990; 86(4):1084-7. PMC: 296835. DOI: 10.1172/JCI114811. View

13.

Ku C, Cooper D, Polychronakos C, Naidoo N, Wu M, Soong R . Exome sequencing: dual role as a discovery and diagnostic tool. Ann Neurol. 2012; 71(1):5-14. DOI: 10.1002/ana.22647. View

14.

Kapur K, Johnson T, Beckmann N, Sehmi J, Tanaka T, Kutalik Z . Genome-wide meta-analysis for serum calcium identifies significantly associated SNPs near the calcium-sensing receptor (CASR) gene. PLoS Genet. 2010; 6(7):e1001035. PMC: 2908705. DOI: 10.1371/journal.pgen.1001035. View

15.

Kobrynski L, Sullivan K . Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet. 2007; 370(9596):1443-52. DOI: 10.1016/S0140-6736(07)61601-8. View

16.

Shoback D . Clinical practice. Hypoparathyroidism. N Engl J Med. 2008; 359(4):391-403. DOI: 10.1056/NEJMcp0803050. View

17.

Nakajima K, Yamazaki K, Kimura H, Takano K, Miyoshi H, Sato K . Novel gain of function mutations of the calcium-sensing receptor in two patients with PTH-deficient hypocalcemia. Intern Med. 2009; 48(22):1951-6. DOI: 10.2169/internalmedicine.48.2459. View

18.

Yi H, Eom Y, Park I, Lee S, Hong S, Juppner H . Identification and characterization of C106R, a novel mutation in the DNA-binding domain of GCMB, in a family with autosomal-dominant hypoparathyroidism. Clin Endocrinol (Oxf). 2011; 76(5):625-33. PMC: 3701386. DOI: 10.1111/j.1365-2265.2011.04256.x. View

19.

Bilezikian J, Khan A, Potts Jr J, Brandi M, Clarke B, Shoback D . Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res. 2011; 26(10):2317-37. PMC: 3405491. DOI: 10.1002/jbmr.483. View

20.

Maret A, Ding C, Kornfield S, Levine M . Analysis of the GCM2 gene in isolated hypoparathyroidism: a molecular and biochemical study. J Clin Endocrinol Metab. 2008; 93(4):1426-32. DOI: 10.1210/jc.2007-1783. View